Ipca Laboratories Says Consolidated Net Profit Hikes 14% To ₹68 Crore, Revenue From Operations Rises To ₹2,247 Crore

New Delhi : Ipca Laboratories on Thursday said its consolidated net profit increased 14 per cent to Rs 68 crore in the fourth quarter ended March 31, 2025.The drug firm reported a net profit of Rs 60 crore during the January-March quarter of 2023-24 financial year.During the quarter, revenue from operations rose to Rs 2,247 crore as compared to Rs 2,033 crore in the year-ago period, Ipca Laboratories said in a regulatory filing.

Net profit stood at Rs 738 crore for 2024-25 fiscal against Rs 547 crore in FY24.Revenue rose to Rs 8,940 crore for the last fiscal from Rs 7,705 crore a year ago.The company said its board has recommended a final dividend of Rs 2 per share for the year ended March 31, 2025.

Shares of Ipca Laboratories were trading 0.67 per cent lower at Rs 1,485.70 apiece on the BSE.

Disclaimer: This story is from the syndicated feed. Nothing has been changed except the headline.